technology #Health #Antivirals #Measles #MeaslesOutbreak #VaccineHesitancy As US measles cases rise, biotech firms start developing new treatments Ars Technica 5h ago
technology #Health #AntiVaccine #PublicHealth #Syndication #VaccineHesitancy What public health professionals can learn from anti-vaccine storytelling Ars Technica Mon
BURST